Follow our Journeys
Sharing success stories internal to Duke Capital Partners and external to our portfolio companies.
Breath of Life: Duke Inventors Secure $5M for Novel Oxygenation Startup
27th Mar 2025
Duke clinician partners with Duke engineers to tackle an elusive critical care challenge: Can oxygen be delivered directly into the bloodstream?
Founder Spotlight: Elle Smyth
Elle Smyth, Co-Founder and CEO of RetailReady, embodies the spirit of technical innovation and entrepreneurship fostered here at Duke University.
10 Years, 60 Startups, $105 Million – and Counting: Duke Capital Partners Leads the Way in Alumni Investing
From its start as one of the first alumni-led venture groups of its kind, Duke Capital Partners continues to connect Duke alumni investors with innovative Duke-affiliated startups – and train the next generation of venture…
VQ Biomedical secures $5M, including a seed round led by Harbright, WIN, and DCP
VQ Biomedical is a Duke University start-up and DCP portfolio company resulting from the collaboration Duke clinicians and engineers.
Read More about VQ Biomedical secures $5M, including a seed round led by Harbright, WIN, and DCP
Tune Therapeutics Names John McHutchison as CEO and Chairman of the Board
John McHutchison, new CEO of Duke spinout and DCP portco Tune, has held professorships and associate directorships at SOM and DCRI.
Read More about Tune Therapeutics Names John McHutchison as CEO and Chairman of the Board
Associate Spotlight: Yunxin Ouyang
Yunxin Ouyang shares how she blends BME PhD research expertise with her work as a DCP Associate.
Tune Therapeutics Completes Over $175M in Series B Financing to Advance Field-Leading Epigenome Editing Programs
Tune Therapeutics, a Duke Capital Partners portfolio company, is a Duke spinout cofounded by Professor Charles Gersbach (BME, Pratt).